(Q42805365)

7 November 2017

title

Thiazolidinediones can rapidly activate AMP-activated protein kinase in mammalian tissues (English)

1 reference

7 November 2017

Nathan K LeBrasseur

1

0 references

Asish K Saha

object named as

Asish K Saha

5

0 references

Stephen R Farmer

object named as

Stephen R Farmer

4

0 references

Neil B Ruderman

object named as

Neil B Ruderman

6

0 references

author name string

Meghan Kelly

2

1 reference

7 November 2017

Tsu-Shuen Tsao

3

1 reference

7 November 2017

Eva Tomas

7

1 reference

7 November 2017

publication date

7 February 2006

1 reference

American Journal of Physiology - Endocrinology and Metabolism

7 November 2017

published in

1 reference

7 November 2017

volume

291

1 reference

7 November 2017

issue

1

1 reference

7 November 2017

page(s)

E175-81

1 reference

Tissue distribution and quantification of the expression of mRNAs of peroxisome proliferator-activated receptors and liver X receptor-alpha in humans: no alteration in adipose tissue of obese and NIDDM patients

7 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2005

Effect of 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside infusion on in vivo glucose and lipid metabolism in lean and obese Zucker rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2005

A novel N-aryl tyrosine activator of peroxisome proliferator-activated receptor-gamma reverses the diabetic phenotype of the Zucker diabetic fatty rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2005

Direct thiazolidinedione action on isolated rat skeletal muscle fuel handling is independent of peroxisome proliferator-activated receptor-gamma-mediated changes in gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2005

Thiazolidinediones, like metformin, inhibit respiratory complex I: a common mechanism contributing to their antidiabetic actions?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2005

Troglitazone action is independent of adipose tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2005

Impaired fatty acid metabolism in type 2 diabetic skeletal muscle cells is reversed by PPARgamma agonists.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2005

Identification of a novel mitochondrial protein (“mitoNEET”) cross-linked specifically by a thiazolidinedione photoprobe

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2005

Thiazolidinediones repress ob gene expression in rodents via activation of peroxisome proliferator-activated receptor gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2005

Activation of AMP kinase enhances sensitivity of muscle glucose transport to insulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2005

Identification of a functional peroxisome proliferator-responsive element in the murine fatty acid transport protein gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2005

The Anti-diabetic drugs rosiglitazone and metformin stimulate AMP-activated protein kinase through distinct signaling pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2005

Acute non-insulin-like stimulation of rat muscle glucose metabolism by troglitazone in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2005

A dominant-negative peroxisome proliferator-activated receptor gamma (PPARgamma) mutant is a constitutive repressor and inhibits PPARgamma-mediated adipogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2005

Role of PPAR gamma in regulating adipocyte differentiation and insulin-responsive glucose uptake.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2005

AICAR administration causes an apparent enhancement of muscle and liver insulin action in insulin-resistant high-fat-fed rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2005

Antidiabetic thiazolidinediones inhibit leptin (ob) gene expression in 3T3-L1 adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2005

Differential effects of rosiglitazone on skeletal muscle and liver insulin resistance in A-ZIP/F-1 fatless mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2005

Troglitazone causes acute mitochondrial membrane depolarisation and an AMPK-mediated increase in glucose phosphorylation in muscle cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2005

Hyperglycemia inhibits insulin activation of Akt/protein kinase B but not phosphatidylinositol 3-kinase in rat skeletal muscle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2005

Acute effects of troglitazone on in vivo insulin action in normal rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2005

An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma)

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2005

Regulating the balance between peroxisome proliferator-activated receptor gamma and beta-catenin signaling during adipogenesis. A glycogen synthase kinase 3beta phosphorylation-defective mutant of beta-catenin inhibits expression of a subset of adip

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2005

PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2005

Effect of acetoacetate on glucose metabolism in the soleus and extensor digitorum longus muscles of the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2005

The mitochondrial carnitine palmitoyltransferase system. From concept to molecular analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2005

Expression of putative fatty acid transporter genes are regulated by peroxisome proliferator-activated receptor alpha and gamma activators in a tissue- and inducer-specific manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2005

Pioglitazone time-dependently reduces tumour necrosis factor-alpha level in muscle and improves metabolic abnormalities in Wistar fatty rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2005

Thiazolidinediones block tumor necrosis factor-alpha-induced inhibition of insulin signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2005

PPARgamma : a nuclear regulator of metabolism, differentiation, and cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2005

AMP kinase and malonyl-CoA: targets for therapy of the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2005

Pioglitazone treatment activates AMP-activated protein kinase in rat liver and adipose tissue in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2005

The hormone resistin links obesity to diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2005

PPAR gamma 2 regulates adipose expression of the phosphoenolpyruvate carboxykinase gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2005

Oligomerization state-dependent activation of NF-kappa B signaling pathway by adipocyte complement-related protein of 30 kDa (Acrp30)

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2005

Contraction-induced changes in acetyl-CoA carboxylase and 5'-AMP-activated kinase in skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2005

Adipose tissue resistin expression is severely suppressed in obesity and stimulated by peroxisome proliferator-activated receptor gamma agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2005

The PPARs: from orphan receptors to drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2005

A family of Acrp30/adiponectin structural and functional paralogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2005

Direct demonstration of lipid sequestration as a mechanism by which rosiglitazone prevents fatty-acid-induced insulin resistance in the rat: comparison with metformin

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2005

Troglitazone induces GLUT4 translocation in L6 myotubes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00453.2005

10.1152/AJPENDO.00453.2005

21 January 2018

Identifiers

DOI

1 reference

7 November 2017

1 reference